Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Jul 1;4(3):196-207.
doi: 10.1016/S2055-6640(20)30271-5.

Highlights from the 20th International Symposium on HIV and Emerging Infectious Diseases (ISHEID) 16-18 May 2018, Marseille, France: from HIV and comorbidities to global health

Christina Psomas  1 , Sabine Kinloch  2 , Caroline Sabin  3 , Vicente Soriano  4 , Caroline Solas  5 , Chloe Orkin  6 , José Bernardino  7 , Adrian Curran  8 , Jean-Pierre Routy  9 , Patricia Enel  10 , Patrick Philibert  1 , Alain Lafeuillade  11
Affiliations
Editorial

Highlights from the 20th International Symposium on HIV and Emerging Infectious Diseases (ISHEID) 16-18 May 2018, Marseille, France: from HIV and comorbidities to global health

Christina Psomas et al. J Virus Erad. .

Abstract

The 20th International Symposium on HIV and Emerging Infectious Diseases took place in Marseille, France. It had a refreshing European look with reinforced partnerships with the European AIDS Clinical Society and the British HIV Association and with international speakers and participants. Topics included HIV and global health, HIV and hepatitis cure, the microbiome and immunotherapies, clinical research and methodology, as well as chemsex, pre-exposure prophylaxis, sexually transmitted infections and emerging infectious diseases. Novel areas of research were also described, such as electronic technology in order to improve HIV management, and the expert patient.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Global health targets
Figure 2.
Figure 2.
Target population for early phase clinical trials: acute and recent HIV infection. Adapted from
Figure 3.
Figure 3.
Major chronic viral pandemics
Figure 4.
Figure 4.
Major HBV therapeutic targets
Figure 5.
Figure 5.
Genital microbiota and HIV transmission
Figure 6.
Figure 6.
Principles of the block and lock strategy
Figure 7.
Figure 7.
Estimate of number of HPV-related lesions/year worldwide
See this image and copyright information in PMC

References

    1. Vella S. From HIV to Global Health. J Virus Erad 2018; 4( Suppl 1): abstract S1.
    1. Vella S., Wilson D. From Durban to Durban: end of AIDS further than hoped. Lancet HIV 2016; 3: e403– 405. - PubMed
    1. Vella S, Wilson D.. Access to medicines: lessons from the HIV response. Lancet HIV 2017: e147– e149. - PubMed
    1. Mothe B, Molto J, Manzardo C et al. . Viral control induced by HIVCONSV vaccines and romidepsin in early treated individuals. Conference on Retroviruses and Opportunistic Infections. February 2017. Seattle, WA, USA. Abstract 119LB.
    1. Cohen MS, Shaw GM, McMichael AJ, Haynes BF.. Acute HIV-1 infection. N Engl J Med 2011; 364: 1943– 1954. - PMC - PubMed

Publication types

LinkOut - more resources